|Description||Agomelatine L(+)-Tartaric acid is classified as a norepinephrine-dopamine disinhibitor (NDDI) due to its antagonism of the 5-HT2C receptor. It is used as an antidepressant drug. It has been approved by FDA in October 2011. It has toxicities, such as Hyperhidrosis, Abdominal pain, Nausea, Vomiting, Diarrhoea, Constipation, Back pain, Fatigue and so on.|
|Synonyms||Acetamide, N-[2-(7-methoxy-1-naphthalenyl)ethyl]-,(2R,3R)-2,3-dihydroxybutanedioate;S-20098 L(+)-Tartaric acid|
|Solubility||DMSO 49 mg/mL; Water <1 mg/mL ; Ethanol 49 mg/mL|
|Application||Agomelatine L(+)-Tartaric acid is used as an antidepressant drug.|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
GMC 2-113 is a selective 5-HT1B antagonist.
GMC 1-165 is an analogue of clozapine with 5-HT2A/2C and hM1 receptor affinities.
Ritanserin is a potent and long-acting 5-HT2 receptor antagonist (Ki = 0.39 nM) with high selectivity for 5-HT2A over 5-HT1 receptors (IC50s = 0.9 nM and >1000 ...
α-Methyl-5-hydroxytryptamine maleate, a salt of α-Methylserotonin maleate, is a 5-HT2B receptor selective agonist with pKi values of 8.4, 6.1 and 7.3 at 5-HT2B,...
(±)-McN 5652 is a potent, orally active 5-HT uptake inhibitor. McN-5652 is characterized by exceptionally high potency as an inhibitor of the uptake of serotoni...
Palonosetron HCl is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting.
Zotepine is a 5-HT2A receptor and dopamine D2 receptor antagonist (Ki = 0.69 and 2.3 nM, respectively) used as an atypical antipsychotic for the treatment of sc...